Company Profile
Arrowhead Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- ARWR
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Arrowhead Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
79.90 USD (-2.56%)
Close
Last updated: June 23, 2026 at 00:00
11.25B USD
Market cap
Why the stock is moving
ARWR is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Arrowhead Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Arrowhead Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Arrowhead Pharmaceuticals follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Arrowhead Pharmaceuticals sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
Arrowhead Pharmaceuticals to Host a Webinar on its Cardiometabolic Pipeline as Part I of the 2026 Summer Series of R&D Webinars
Source: Arrowhead Pharmaceuticals
- 03
Arrowhead Pharmaceuticals to Participate in Upcoming June 2026 Events
Source: Arrowhead Pharmaceuticals
- 04
Arrowhead Pharmaceuticals Presents New Clinical Data on RNAi-based Obesity and MASH Candidate ARO-INHBE at EASL 2026
Source: Arrowhead Pharmaceuticals
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Arrowhead Pharmaceuticals (ARWR)?
Arrowhead Pharmaceuticals (ARWR) most recently closed at 79.90 USD, a -2.56% move versus the previous session.
What is the market cap of Arrowhead Pharmaceuticals (ARWR)?
Arrowhead Pharmaceuticals currently has a market capitalization of 11.25B USD on BioPharmSignal.
What does Arrowhead Pharmaceuticals do?
Arrowhead Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is ARWR stock listed?
Arrowhead Pharmaceuticals (ARWR) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Arrowhead Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Arrowhead?
Arrowhead Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Arrowhead Pharmaceuticals targeting with Arrowhead?
Arrowhead Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Pharmaceuticals?
Arrowhead Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.